Skip to main content

post mortem of aquisitions

This is a post as an entrepreneur, shareholder, observer of the big league M&A.

After reading Berkshire Hathaway last shareholder letter a few things jumped at me, due to my past experiences:
  • how to really think about swapping shares in a merger situation
  • looking back to analyze past acquisitions (or post-mortem analysis of acquisitions)
    • how are my next investments judged based on the performance of the actors involved in the past M&A
    • what is the time-horizon to draw a line and judge the benefits of M&A
           I have been in both positions (company I worked for being acquired or acquiring). In my direct experience acquiring a company proved to be a bad decision for shareholders. There is a wide spread opinion the larger you are as company the better you are noticed. There were well known cases when number two or three in the industry jumped to swallow number one just because the egos were big and debt was cheap. It happened for me as a shareholder of companies like First Data Corporation, Nokia, Kingsway Financial etc...

        I gained some money in the process, but probably I lost in the long term. The "agency problem" of the management is well studied but not solved in the real world. Will management make a short-gain move for themselves and let the shareholders holding the bag (with the "help" of corporate raiders ?). Companies I admired and (in consequence) invested in them ended up as withered images later on after milked by hedge funds and private investors (remember the map company aka HERE maps or First Data ?).

       If you are looking at the history of First Data after the acquisition by KKR, it makes you wonder, was it a financial feat or a real gain for the acquirer ?! What is life after you were "optimized" by the corporate raiders? First Data is now back, independent. Is it better, what has changed in all the year in private ownership? Is that an interesting case for MBAs?

There are many situations were the initial step - announcement on acquisition is lifting the price and, in time, the whole process unfolds in a totally different direction. In recent times was a catastrophic case of Walgreens trying to acquire Rite Aid - a $10 billion mega-merger which was a tragic-soap opera in flux with Trump emergent figure as president. Trump was an influence because of the rhetoric in "fixing-the-economy" and sudden realization that "America will be great again' meant no mega-merger to milk the American people was palatable. The botched sales of Rite Aid has emptied the pockets of many shareholders. Today, Rite Aid is at a value not seen since 2013. Good play, Rite Aid CXOs!

On the other hand, the fixer-uppers in finance moved there sights on smaller players with potential - see KKR move on Medtronic and Gilead acquisitions of Kite Pharma. The low interest rates is still an incentive for harnessing on debt for the near future.

I am waiting for Mr.Buffett to point when the market is so enticing for him to punch the cash bag for a big acquisition.

Comments

Popular posts from this blog

When gaffes are used strategically

Photo by Kyle Head on Unsplash You probably heard that swimming in rough waters in life will reveal your own character and of all the people with you, caught in that moment. It is always unexpected and, exactly as in movies, it begins with a peaceful background and a monotone sound. Everything is unfolding slowly and without any clues that deep gaps will be revealed in any way. It is like a crack in someone's emotional fabric which becomes a wrecking ball for the characters caught in the event, for a short time span, sufficient to project them on a different life orbit, for good. Some people are calling those events "interventions", others fear them as "dark spots" where secrets are emerging as an iceberg unbalanced by some life event. The repercussions are deep and memorable and entail subsequent turmoils, like a burning lava which will flow down for many days to find a peaceful landscape to cool off. The characters are the same like in normal life ...

The Big Split

Photo by CDC on Unsplash   Detect immunity One of the numbers broadcasted every day is the number of COVID-19 patients who recovered. Instead of being fixed on detecting people with corona virus, we should be fixed on detecting the ones who had a mild version of corona virus or even were asymptomatic. Once we know they can freely move, socially mark them in a certain way (with a special certificate).  They could be the soldiers of opening closed businesses or helping important economic sectors. They are on the other side of the fear, all the COVID-19 restrictions should not apply to them. It is not known for how long is the immunity lasting, but at least, these people should come back and revive the industries and get the jobs and make the economy re-start. It is a small number, but they can propel some ideas for the ones in the isolation (see below). That should be the second most important decision of our governments - detect immunity, instead of just...

The sprint to stop an epidemic - Corona virus

Photo by Trust "Tru" Katsande on Unsplash I was reading about the developing efforts for a vaccine reflected through the stock market. It happened to have a few shares of the VIR Biotechnology ( VIR ) company when the chase of finding a vaccine started. It was an incredible ride, even for a guy accustomed with the up-and-downs of the shares in a company and the political game played when companies are bought or acquired. Just for illustration, please see the chart of this stock for a three month period. There is excitement, at the beginning  of March about the possibility of developing a vaccine for Corona virus, and the stock surpasses 70$/share when before is was lingering under the 17$/share threshold. There are many companies in the race - Moderna ( MRNA ), Gilead ( GILD ), Inovio Pharmaceuticals ( INO ) and probably a few of them will find a virus. What I don't understand is the effort spent in parallel of fighting the same cause. It is a lot of ...